BIOMAT Database Logo BIOMAT Database Logo

[Management of recurrent herpes simplex using levamisole]. 1979

C Luderschmidt, and H H Wolff

The therapeutic effect of levamisole was tested in a double blind and open clinical study in 30 patients with recurrent labial and genital herpes simplex. The frequency, the duration and the painfulness of the herpes eruptions were improved significantly under levamisole treatment. Agranulocytosis is an important adverse reaction which restricts the practical use of the substance. The increase of phagocytosis of granulocytes and macrophages and the normalization of defective cell mediated immune reactions are the supposed mechanisms of levamisole action.

UI MeSH Term Description Entries
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D008297 Male Males
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013268 Stimulation, Chemical The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Stimulation,Chemical Stimulations,Stimulations, Chemical

Related Publications

C Luderschmidt, and H H Wolff
Treatment of recurrent herpes simplex labialis with levamisole.
May 1979, Antimicrobial agents and chemotherapy,
C Luderschmidt, and H H Wolff
[Levamisole in the therapy of recurrent herpes simplex labialis].
April 1980, Centro de Estudios de Recursos Odontologicos para el Nino : CERON,
C Luderschmidt, and H H Wolff
Failure of levamisole in herpes simplex.
October 1977, Lancet (London, England),
C Luderschmidt, and H H Wolff
Management of recurrent oral herpes simplex infections.
March 2007, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics,
C Luderschmidt, and H H Wolff
Recurrent herpes infections and levamisole.
January 1976, Revista latinoamericana de microbiologia,
C Luderschmidt, and H H Wolff
Treatment of herpes simplex keratitis with levamisole.
June 1978, Archives of ophthalmology (Chicago, Ill. : 1960),
C Luderschmidt, and H H Wolff
Diagnosis and management of recurrent herpes simplex infections.
September 2002, Journal of the American Dental Association (1939),
C Luderschmidt, and H H Wolff
[Clinical evaluation of the use of levamisole in treatment of recurrent labial herpes simplex].
November 1979, Ars curandi em odontologia,
C Luderschmidt, and H H Wolff
Recurrent herpes simplex.
April 1982, Canadian Medical Association journal,
C Luderschmidt, and H H Wolff
Recurrent herpes simplex.
November 1982, Canadian Medical Association journal,
Copied contents to your clipboard!